Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

9 treatments under study, led by Calcium Gluconate

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (2)
Phase 2 (1)

Trial Status

Completed1
Suspended1
Not Yet Recruiting1
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (4)

Showing 4 of 4 trials
NCT06235749Not ApplicableRecruitingPrimary

Administration Of Calcium Gluconate for The Reduction of Blood Loss During Elective Cesarean Delivery

NCT07438171Not Yet Recruiting

Maternal Satisfaction After Spinal Anesthesia for Cesarean Delivery

NCT06505915Not ApplicableCompletedPrimary

Carbohydrate Loading Fasting Protocol Versus 'Sip Til Send'

NCT01571791Phase 2Suspended

Perioperative Ketorolac-lidocaine in the Patients With Valvular Heart Diseases During Cesarean Delivery

Showing all 4 trials

Research Network

Common Treatments

  • Calcium Gluconate1
  • Bupivacaine 05 Hyperbaric Morphine And Fentanyl 151
  • Sodium Chloride1
  • Pre Op Carbohydrate Drink1
  • Bupivacaine Morphine And Fentanyl 201

Active Sponsors

  • The Rotunda Hospital1
  • University of Novi Sad1
  • Mansoura University1
  • Rambam Health Care Campus1

Related Conditions

  • Fasting 6h For Solid 2h For Clear Fluid1
  • Parturients1
  • Valve Heart Disease1

Activity Timeline